Building Medical Devices Around Clinical Needs

​Join us for the next Cambridge NeuroTalk on the 28 October. 

​This session will be on: 'Building Medical Devices Around Clinical Needs.' Exploring how to work effectively with clinicians, understand patient pathways and ensure technologies address real clinical challenges.

​Presentation Outline:

​Building Medical Devices Around Clinical Needs
Working with clinicians, reading the patient pathway, and designing for the real needs.

​Every medical device team sets out to improve things for patients, doctors and the health systems their products will be used in. Yet plenty of technically excellent devices never make that difference because they solved the wrong problem or solved the right one in a way that didn’t fit how care is delivered.

​This talk explores what a “clinical need” really is, the importance of understanding the patient pathway: the people, decisions, and workflow around a procedure, not just the procedure itself; and how to involve clinicians and users throughout the development process.

​If you want to launch your next device confident that it will make a meaningful difference for patients and clinicians, and get adopted, not just approved, this talk is for you.

​Our speaker: Dr Quentin Harmer

​

​

​Quentin is an engineer, technologist, and mentor, with over twenty-five years’ experience in leading the development of advanced medical devices and drug-delivery systems. He works at the interface of technology, clinical practice and medical regulation to understand the clinical needs to shape the development of new medical technologies and products.

​Most recently he was Chief Technology Officer at Endomag and Global Head of Breast Surgery R&D for Hologic. Endomag’s surgical guidance systems allow surgeons to locate tumours and stage cancers more accurately and easily. Quentin joined as employee number two, and led the development of Endomag’s product portfolio, IP and clinical strategy. Today Endomag is part of global women’s health company, Hologic, its products are used in more than 40 countries on six continents, and on average a breast cancer patient is treated using them every four minutes.

​Prior to that he worked with Vectura, a developer of inhaled pharmaceuticals, helping to establish their device development centre in Cambridge, creating new inhaled therapies for asthma and COPD. He is an inventor on over 30 patent families and registered designs.